Common Antibiotics for General Practice in India
For safe and effective antibiotic prescribing in general practice, amoxicillin-clavulanate is the most versatile first-line option for respiratory, skin, and urinary tract infections, with specific alternatives based on infection type, severity, and patient factors. 1
Urinary Tract Infections (UTIs)
Uncomplicated UTIs/Cystitis
First-line:
- Nitrofurantoin 100 mg PO four times daily for 5 days
- Fosfomycin 3 g single dose
- Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days
Second-line (if resistance concerns or allergies):
- Cephalexin 500 mg four times daily for 5-7 days
- Cefuroxime 500 mg twice daily for 5-7 days
Complicated UTIs/Pyelonephritis
Outpatient treatment:
- Ciprofloxacin 500 mg twice daily for 7-14 days 2
- Amoxicillin-clavulanate 875/125 mg twice daily for 10-14 days
Inpatient treatment:
- Piperacillin-tazobactam 3.375 g IV every 6 hours
- Ceftriaxone 1-2 g IV daily
Respiratory Tract Infections
Acute Bacterial Sinusitis
First-line:
- Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 3
Alternatives (penicillin allergy):
- Doxycycline 100 mg twice daily for 5-7 days
- Cefuroxime 500 mg twice daily for 5-7 days
Community-Acquired Pneumonia
Outpatient (mild):
- Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days
- Azithromycin 500 mg on day 1, then 250 mg daily for 4 days 4
Inpatient (moderate-severe):
- Ceftriaxone 1-2 g IV daily plus Azithromycin 500 mg IV/PO daily
- Piperacillin-tazobactam 3.375 g IV every 6 hours for severe cases
Skin and Soft Tissue Infections
Impetigo
First-line:
- Mupirocin ointment applied to lesions twice daily for 5-7 days
- Retapamulin ointment applied to lesions twice daily for 5 days 1
Oral therapy (extensive lesions):
- Cephalexin 250-500 mg four times daily for 7 days
- Amoxicillin-clavulanate 875/125 mg twice daily for 7 days
Cellulitis (non-purulent)
Outpatient (mild):
- Cephalexin 500 mg four times daily for 5-10 days
- Amoxicillin-clavulanate 875/125 mg twice daily for 5-10 days
Inpatient (moderate-severe):
- Cefazolin 1 g IV every 8 hours
- Clindamycin 600-900 mg IV every 8 hours (for penicillin allergy)
Abscess/Purulent SSTI (MRSA concern)
Outpatient:
- Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily for 7-10 days
- Clindamycin 300-450 mg four times daily for 7-10 days
Inpatient:
- Vancomycin 15-20 mg/kg IV every 12 hours
- Linezolid 600 mg IV/PO every 12 hours
Animal/Human Bite Infections
First-line:
- Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 1
Alternative (penicillin allergy):
- Doxycycline 100 mg twice daily plus metronidazole 500 mg three times daily
Practical Prescribing Considerations
Dosage Adjustments
- Renal impairment:
- CrCl 30-50 mL/min: Use standard doses with increased interval
- CrCl 5-29 mL/min: Reduce dose by 50% or increase interval
- Hemodialysis: Dose after dialysis
Duration of Therapy
- Most uncomplicated infections: 5-7 days
- Complicated infections: 10-14 days
- Bone/joint infections: 4-6 weeks minimum
Common Pitfalls to Avoid
- Overuse of fluoroquinolones: Reserve for specific indications due to resistance concerns and adverse effects
- Inappropriate use of broad-spectrum antibiotics: Start narrow when possible
- Inadequate dosing: Ensure optimal dosing especially in critically ill patients 5
- Failure to adjust for local resistance patterns: Consider regional resistance data when selecting empiric therapy 6
Special Populations
- Pregnant women: Avoid tetracyclines, fluoroquinolones, and trimethoprim in first trimester
- Children under 8: Avoid tetracyclines due to dental staining
- Elderly: Consider reduced dosing based on renal function and drug interactions
Regional Resistance Considerations
In areas with high antibiotic resistance (common in India):
- Avoid empiric use of trimethoprim-sulfamethoxazole for UTIs (high resistance rates) 6
- Consider higher doses of amoxicillin-clavulanate for respiratory infections
- For suspected ESBL infections, consider carbapenems or newer agents like ceftazidime-avibactam 1
By following these evidence-based guidelines, general practitioners can provide safe and effective antibiotic therapy while minimizing the risk of treatment failure and antibiotic resistance.